J. Dunning, M. Versteegh, A. Fabbri, A. Pavie, P. Kolh et al., Nashef SA: Guideline on antiplatelet and anticoagulation management in cardiac surgery, Eur J Cardiothorac Surg, vol.34, pp.73-92, 2008.

V. Gras-champel, V. Brenet-dufour, J. Moragny, H. Masson, E. Davidau et al., Quantification of the part allocated to the preventability of vitamin K antagonists therapy bleeding events, Therapie, vol.65, pp.261-268, 2010.

P. Pouyanne, F. Haramburu, J. L. Imbs, and B. Bégaud, Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres, BMJ, vol.320, p.1036, 2000.

M. G. Lansberg, M. J. Donnell, P. Khatri, E. S. Lang, M. N. Nguyen-huynh et al., Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, vol.141, pp.601-637, 2012.

F. Cosserat, S. Colnat-coulbois, O. Klein, G. Audibert, N. Petitpain et al., Hémorragies intracrâniennes et anticoagulants oraux: étude des facteurs pronostiques à partir d'une série de 186 cas, Neurochirurgie, vol.55, pp.11-16, 2009.

P. Grillo, L. Velly, and N. Bruder, Accident vasculaire cérébral hémorragique: nouveautés sur la prise en charge, Ann Fr Anesth Reanim, vol.25, pp.868-873, 2006.

D. Poli, E. Antonucci, S. Testa, A. Tosetto, W. Ageno et al., Result of a prospective collaborative study on elderly patients followed by Italian centres for anticoagulation, Circulation, vol.124, pp.824-829, 2011.

S. J. Connolly, M. D. Ezekowitz, S. Yusuf, J. Eikelboom, J. Oldgren et al., RE-LY Steering Committee and Investigators, Wallentin L: Dabigatran versus Warfarin in Patients with Atrial fibrillation, N Engl J Med, vol.361, pp.1139-1151, 2009.

M. R. Patel, K. W. Mahaffey, J. Garg, G. Pan, D. E. Singer et al., ROCKET AF Investigators: Rivaroxaban versus warfarin in nonvalvular atrial fibrillation, N Engl J Med, vol.365, pp.883-91, 2011.

F. Claudot, A. F. Fresson, J. Calvez, T. Coudane, H. Bonaïti-pellié et al., Ethics and observational studies in medical research: various rules in a common framework, Int J Epidemiol, vol.38, issue.4, pp.1104-1108, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00377284

K. Azarnoush, L. Camilleri, B. Aublet-cuvelier, E. Geoffroy, C. Dauphin et al., Results of the first randomized French study evaluating self-testing of the International Normalized Ratio, J Heart Valve Dis, vol.20, pp.518-525, 2011.

M. Coppens, J. W. Eikelboom, R. G. Hart, S. Yusuf, G. Y. Lip et al., The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy, Eur Heart J, vol.34, pp.170-176, 2013.

G. Palareti, N. Leali, S. Coccheri, M. Poggi, C. Manotti et al., Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy, Lancet, vol.348, pp.423-428, 1996.

B. Cucchiara, S. Messe, L. Sansing, S. Kasner, and P. Lyden, Hematoma Growth in Oral Anticoagulant Related Intracerebral Hemorrhage, Stroke, vol.11, pp.2993-2996, 2008.

M. Tonolini, S. Ippolito, F. Patella, M. Petullà, and R. Bianco, Hemorrhagic complications of anticoagulant therapy: role of multidetector computed tomography and spectrum of imaging findings from head to toe, Curr Probl Diagn Radiol, vol.41, pp.233-247, 2012.

R. M. Bauersachs, Use of anticoagulants in elderly patients, Thromb Res, vol.129, pp.107-115, 2012.

E. G. Butchart, N. Payne, H. H. Li, K. Buchan, K. Mandana et al., Better anticoagulation control improves survival after valve replacement, J Thorac Cardiovasc Surg, vol.123, pp.715-723, 2002.

K. Azarnoush, E. Dorigo, B. Pereira, C. Dauphin, E. Geoffroy et al., Mid-term results of self-testing of the international normalized ratio in adults with a mechanical heart valve, Thromb Res, 2013.

C. Van-walraven, N. Oake, P. S. Wells, and A. J. Forster, Burden of potentially avoidable anticoagulant-associated hemorrhagic and thromboembolic events in the elderly, Chest, vol.131, pp.1508-1515, 2007.

E. Feldmann, J. P. Broderick, W. N. Kernan, C. M. Viscoli, L. M. Brass et al., Major risk factors for intracerebral hemorrhage in the young are modifiable, Stroke, vol.36, pp.1881-1885, 2005.

T. Brott, K. Thalinger, and V. Hertzberg, Hypertension as a risk factor for spontaneous intracerebral hemorrhage, Stroke, vol.17, pp.1078-1083, 1986.

. Risch, Submit your next manuscript to BioMed Central and take full advantage of: ? Convenient online submission ? Thorough peer review ? No space constraints or color figure charges ? Immediate publication on acceptance ? Inclusion in PubMed, CAS, Scopus and Google Scholar ? Research which is freely available for redistribution, Journal of Cardiothoracic Surgery, vol.19, p.166, 2014.